Last Price$1.3(9.4%)
Market Cap$8,155.2K
(23.7%)
Industry median - 3.3%
5Y Historical average - 6.5%
(11.9%)
Industry median - 9.2%
5Y Historical average - 19.3%
(63.9%)
Industry median - 9.0%
5Y Historical average - (22.5%)
(12.5%)
Industry median - 4.2%
5Y Historical average - 19.2%
POAI Growth Rating
POAI Growth rating
3.0
POAI Growth rating performance
POAI Growth Metrics
Annual
Quarterly
LTM
Industry Median
5Y Historical Average
Benchmark
Competing with POAI Growth
Overview
Ratings
Intrinsic Value
Valuation
Growth
Profitability
Health
Capital allocation
Momentum
Earnings
Dividends
Company name | Market Cap | Growth score | Revenue Growth
(5Y CAGR) | Revenue Growth
(YoY) | Revenue Growth
(FWD) | EPS Growth
(5Y CAGR) | EPS Growth
(YoY) | EPS Growth
(FWD) | FCF Growth
(5Y CAGR) | FCF Growth
(YoY) |
$8,155.2K | 3.0 | 0.1% | (23.7%) | (21.7%) | (44.8%) | (63.9%) | (40.2%) | 10.8% | (12.5%) | |
$207.3B | 7.7 | 13.3% | 17.2% | 14.2% | 16.2% | 65.6% | 20.5% | (1.7%) | 43.7% | |
$66.3B | 5.9 | 3.5% | 5.9% | 9.0% | 17.0% | 41.9% | 145.1% | 0.7% | 10.9% | |
$46.6B | 5.8 | 5.7% | 3.6% | 2.8% | N/A | (26.4%) | 50.8% | 20.0% | 14.4% | |
$34.6B | 7.5 | 12.1% | 12.9% | 9.2% | 4.9% | (33.4%) | 35.4% | 27.0% | 47.1% | |
$18.6B | 5.4 | 8.0% | 8.4% | 5.8% | (26.9%) | 32.2% | 102.2% | (7.3%) | 34.0% | |
$17.9B | 4.1 | 2.5% | (14.0%) | 148.7% | N/A | 188.4% | N/A | (16.7%) | (45.3%) | |
$16.9B | 5.0 | 9.5% | (1.9%) | 5.3% | 15.6% | (15.6%) | 10.7% | 2.8% | (33.3%) | |
$14.7B | 7.6 | 3.6% | 1.8% | 3.4% | 27.9% | 50.0% | 27.1% | 16.2% | 32.2% | |
$10.4B | 6.0 | 17.4% | 2.3% | 1.9% | N/A | N/A | 161.9% | (0.5%) | 2,170.3% | |
$9,757.8M | 6.7 | 4.6% | 2.7% | 5.0% | 8.2% | 30.2% | 4.4% | 5.5% | 36.0% |
FAQ
What is the Predictive Oncology Inc. (POAI) revenue growth?
The Predictive Oncology Inc. (POAI) revenue growth is (23.7%), which is lower than the industry median of 3.3% and the 5-year historical average of 6.5%.
What is the Predictive Oncology Inc. (POAI) operating income growth?
The Predictive Oncology Inc. (POAI) operating income growth is (11.9%), compared to the industry median of 9.2% and the 5-year historical average of 19.3%.
What is the Predictive Oncology Inc. (POAI) EPS (Earnings Per Share) growth?
The Predictive Oncology Inc. (POAI) EPS growth is (63.9%), compared to the industry median of 9.0% and the 5-year historical average of (22.5%).
What is the Predictive Oncology Inc. (POAI) Free Cash Flow (FCF) growth?
The Predictive Oncology Inc. (POAI) Free Cash Flow growth is (12.5%), compared to the industry median of 4.2% and the 5-year historical average of 19.2%.